November 2017

posted 11.07.2017
By Andrew Reynolds Over the past several years, there has been a lot of interest in hepatitis C (HCV)—television commercials about new HCV drugs, increased media coverage on drug prices and even discussion among presidential candidates.For a disease called the “silent epidemic,” that’s a fair…